Prostate Cancer Sample Clauses

Prostate Cancer. Goals: Reduce prostate cancer mortality. Reduce disparities in the mortality of prostate cancer. Monitor the proportion of men who have had a PSA test and a digital rectal examination. Objective 1: Increase public education about prostate cancer. Objective 2: Continue to monitor research findings regarding the effectiveness of primary and secondary prevention inter- ventions in reducing prostate cancer mortality. Objective 3: Promote informed decisionmaking prior to screening with PSA and digital rectal examination. Objective 4: Promote education about prostate cancer treatment and support services for patients diagnosed with prostate cancer. Objective 5: Monitor research in primary, secondary, and tertiary prevention.
AutoNDA by SimpleDocs
Prostate Cancer. Prostate cancer is originally confined to the prostate gland then grows slowly, where it may not cause serious destruction. However, some types of prostate cancer are aggressive and can spread quickly, and other types grow slowly and may need minimal or even no treatment (Xxxxxx et al., 2016).
Prostate Cancer. More than 1.1 million cases of prostate cancer were recorded in 2012, accounting for around 8 per cent of all new cancer cases and 15 per cent in men (Xxxxxx et al., 2015). Despite this, it remains the second leading cause of death in men. The vast majority of prostate tumours arise from epithelial tissues, resulting in adenocarcinomas. The accepted paradigm is that prostate carcinoma usually arises from lesions termed prostate intraepithelial neoplasia (PIN). This condition is characterised by many features reminiscent of early stage cancer, including loss of cellular polarity, nuclear atypia, and focal dysplasia, resulting in displaced cells lining the acinar and luminal spaces (Xxxxxxx, 2009).
Prostate Cancer. Moderator: Xxxxxx Xxxxx, M.D., Emory University School of Medicine 5:00 p.m. – 5:30 p.m. Election of Chair and Co-Chair of the EDRN Steering Committee Appointment of Chairs and Co-Chairs of Collaborative Groups New Chair of EDRN Steering Committee 5:30 p.m. Adjourn for the Day Friday, October 21, 2016

Related to Prostate Cancer

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Prosthodontics We Cover prosthodontic services as follows: • Removable complete or partial dentures, for Members 15 years of age and above, including six (6) months follow-up care; • Additional services including insertion of identification slips, repairs, relines and rebases and treatment of cleft palate; and • Interim prosthesis for Members five (5) to 15 years of age. We do not Cover implants or implant related services. Fixed bridges are not Covered unless they are required: • For replacement of a single upper anterior (central/lateral incisor or cuspid) in a patient with an otherwise full complement of natural, functional and/or restored teeth; • For cleft palate stabilization; or • Due to the presence of any neurologic or physiologic condition that would preclude the placement of a removable prosthesis, as demonstrated by medical documentation.

  • Vaccination and Inoculation (a) The Employer agrees to take all reasonable precautions, including in-service seminars, to limit the spread of infectious diseases among employees.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Diagnosis For a condition to be considered a covered illness or disorder, copies of laboratory tests results, X-rays, or any other report or result of clinical examinations on which the diagnosis was based, are required as part of the positive diagnosis by a physician.

  • Insulin Insulin will be treated as a prescription drug subject to a separate copay for each type prescribed.

  • Musculoskeletal Injury Prevention and Control (a) The Hospital in consultation with the Joint Health and Safety Committee (JHSC) shall develop, establish and put into effect, musculoskeletal prevention and control measures, procedures, practices and training for the health and safety of employees.

Time is Money Join Law Insider Premium to draft better contracts faster.